Search research articles
Contact Us
Filters
Showing results (401-410 of 425) with videos related to
Page
of 43
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
September 6, 2024
A longitudinal study assessing the impact of elexacaftor/tezacaftor/ivacaftor on gut transit and function in people with cystic fibrosis using magnetic resonance imaging (MRI)
Alexander Yule, Christabella Ng, Arantxa Recto, et al.
Chemical Research in Toxicology
|
April 23, 2024
Burn Pit Smoke Condensate-Mediated Toxicity in Human Airway Epithelial Cells
Arunava Ghosh, Alexis Payton, Samuel C Gallant, et al.
The European Respiratory Journal
|
May 30, 2015
Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis
Helen L Barr, Nigel Halliday, Miguel Cámara, et al.
Thorax
|
August 6, 2017
The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers
Nicola J Rowbotham, Sherie Smith, Paul A Leighton, et al.
Alzheimer'S Research & Therapy
|
June 19, 2025
A longitudinal study of the 5xFAD mouse retina delineates Amyloid beta (Aβ)-mediated retinal pathology from age-related changes
Savannah A Lynn, Sudha Priya Soundara Pandi, Aida Sanchez-Bretano, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
October 25, 2016
Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study
Helen L Barr, Nigel Halliday, David A Barrett, et al.
Journal of Medical Microbiology
|
October 1, 2021
2-Alkyl-4-quinolone quorum sensing molecules are biomarkers for culture-independent <i>Pseudomonas aeruginosa</i> burden in adults with cystic fibrosis
Nur Masirah M Zain, Karmel Webb, Iain Stewart, et al.
The European Respiratory Journal
|
October 21, 2009
Respiratory medicines for children: current evidence, unlicensed use and research priorities
A R Smyth, A Barbato, N Beydon, et al.
Mayo Clinic Proceedings. Digital Health
|
June 26, 2025
CF Tummy Tracker: A Cystic Fibrosis-Specific Patient-Reported Outcome Measure for Daily Gastrointestinal Symptom Burden
Rebecca J Calthorpe, Hisham A Saumtally, Laura M Howells, et al.
Thorax
|
December 16, 2015
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
R Andres Floto, Kenneth N Olivier, Lisa Saiman, et al.
Page
of 43
Search research articles
Search
Showing results (401-410 of 425) with videos related to
Sort By:
Page
of 43
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
September 6, 2024
A longitudinal study assessing the impact of elexacaftor/tezacaftor/ivacaftor on gut transit and function in people with cystic fibrosis using magnetic resonance imaging (MRI)
Alexander Yule, Christabella Ng, Arantxa Recto, et al.
Chemical Research in Toxicology
|
April 23, 2024
Burn Pit Smoke Condensate-Mediated Toxicity in Human Airway Epithelial Cells
Arunava Ghosh, Alexis Payton, Samuel C Gallant, et al.
The European Respiratory Journal
|
May 30, 2015
Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis
Helen L Barr, Nigel Halliday, Miguel Cámara, et al.
Thorax
|
August 6, 2017
The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers
Nicola J Rowbotham, Sherie Smith, Paul A Leighton, et al.
Alzheimer'S Research & Therapy
|
June 19, 2025
A longitudinal study of the 5xFAD mouse retina delineates Amyloid beta (Aβ)-mediated retinal pathology from age-related changes
Savannah A Lynn, Sudha Priya Soundara Pandi, Aida Sanchez-Bretano, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
October 25, 2016
Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study
Helen L Barr, Nigel Halliday, David A Barrett, et al.
Journal of Medical Microbiology
|
October 1, 2021
2-Alkyl-4-quinolone quorum sensing molecules are biomarkers for culture-independent <i>Pseudomonas aeruginosa</i> burden in adults with cystic fibrosis
Nur Masirah M Zain, Karmel Webb, Iain Stewart, et al.
The European Respiratory Journal
|
October 21, 2009
Respiratory medicines for children: current evidence, unlicensed use and research priorities
A R Smyth, A Barbato, N Beydon, et al.
Mayo Clinic Proceedings. Digital Health
|
June 26, 2025
CF Tummy Tracker: A Cystic Fibrosis-Specific Patient-Reported Outcome Measure for Daily Gastrointestinal Symptom Burden
Rebecca J Calthorpe, Hisham A Saumtally, Laura M Howells, et al.
Thorax
|
December 16, 2015
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
R Andres Floto, Kenneth N Olivier, Lisa Saiman, et al.
Page
of 43